Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.

1mon ago, source: Business Insider

Agile Therapeutics, Inc. (“Agile”) (OTCQB: AGRX), a women's healthcare company, today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud ...

AGRX Agile Therapeutics, Inc.

7d ago, source: Seeking Alpha

Agile Therapeutics, Inc., a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States.

Kazia Therapeutics (KZIA) Soars 490% in a Week: Here's Why

14d ago, source: Nasdaq

The GBM AGILE study is also evaluating multiple other novel investigational therapies, which also include those developed by Bayer, Kintara Therapeutics, and Biohaven Pharmaceuticals. In the past ...

Kintara Therapeutics Inc (KTRA)

4d ago, source: Investing

Kintara Therapeutics, Inc. is a clinical-stage biopharmaceutical ... VAL-083 is being evaluated in all three GBM patient subtypes in the GBM AGILE Study: newly diagnosed methylated MGMT; newly ...

Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.

1mon ago, source: Stockhouse

Agile Therapeutics, Inc. (“Agile”) (OTCQB: AGRX), a women's healthcare company, today announced that it has entered into a definitive merger agreement (“Merger ...

Agile Therapeutics Inc AGRX

16d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.

1mon ago, source: Yahoo Finance

PRINCETON, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (“Agile”) (OTCQB: AGRX), a women's healthcare company, today announced that it has entered into a definitive merger ...

Agile Therapeutics, Inc. (AGRX)

1mon ago, source: Yahoo Finance

Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript March 28, 2024 Agile Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.46 EPS, expectations were $-0.92.